TrialEuropean journal of nuclear medicine and molecular imaging2022

Co-clinical FDG-PET radiomic signature in predicting response to neoadjuvant chemotherapy in triple-negative breast cancer.

Sudipta Roy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.